News & Updates

Pregnant women with epilepsy face considerably greater risk of severe morbidity as well as maternal and perinatal mortality, according to a study.

While the MIND* diet has been shown to boost cognitive health, new research suggests that this effect is partially explained by reduced brain arteriosclerosis risk.

Drinking coffee or tea daily appears to be associated with slower cognitive decline, particularly fluid intelligence, in older adults, according to a recent study presented at AAIC 2024.

In the treatment of Parkinson’s disease (PD), faecal microbiota transplantation (FMT) is safe but does not appear to deliver clinically meaningful improvements, according to a study.

People with cataracts may be at elevated risk of vascular dementia and reduced total brain volumes by way of vascular and non-Alzheimer’s disease (AD) mechanisms, according to a study.

More than one-fifth of patients with acute cerebral ischaemia (ACI) appear to be receiving statins unnecessarily, which has the potential to cause higher than 5,600 adverse events (AEs) each year, including diabetes, myopathy, and eye disease, according to the results of a meta-analysis.

New drug applications approved by US FDA as of 16-31 July 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.